Flexible DNA Nanoclaws Offer Multivalent and Powerful Spatial Pattern-Recognition for Tumor Cells
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c03382 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Kang Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongshan City People's Hospital, 528403 Zhongshan, Guangdong, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Epithelial Cell Adhesion Molecule, Erb-b2 Receptor Tyrosine Kinases, DNA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Zhongshan City People's Hospital, 528403 Zhongshan, Guangdong, China.
- School of Pharmaceutical Sciences, Sun Yat-Sen University, 510006 Guangzhou, Guangdong, China.
ORCID-Profile: Yuanqing Zhang
Förderung
- Guangzhou Municipal Science and Technology Project
- National Natural Science Foundation of China
Zitieren
APA
Chen, K., Mao, M., Huo, L., Wang, G., Pu, Z., & Zhang, Y. (2024). Flexible DNA Nanoclaws Offer Multivalent and Powerful Spatial Pattern-Recognition for Tumor Cells. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c03382
Vancouver
Chen K, Mao M, Huo L, Wang G, Pu Z, Zhang Y. Flexible DNA Nanoclaws Offer Multivalent and Powerful Spatial Pattern-Recognition for Tumor Cells. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c03382
BibTeX
@article{Chen2024,
author = {Chen, Kang and Mao, Miao and Huo, Lian and Wang, Guanzhao and Pu, Zhe and Zhang, Yuanqing},
title = {Flexible DNA Nanoclaws Offer Multivalent and Powerful Spatial Pattern-Recognition for Tumor Cells},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c03382}
}
EUVIMED